PMID: 6977010Feb 1, 1982Paper

Ubiquitous nonimmunoglobulin p-azobenzenearsonate-binding molecules from lymphoid cells

The Journal of Experimental Medicine
A F Clark, J D Capra

Abstract

A ubiquitous nonimmunoglobulin molecule that binds p-azobenzenearsonate (ABA) has been detected in the cytoplasm of several murine cell lines, including T cell hybridomas as well as in normal liver and spleen. Similar to many recently described antigen-specific T cell factors, this ABA-binding protein has a 62,000 mol wt, and, when analyzed by direct binding, the molecule reacts with several different rabbit anti-idiotypic antisera specific to the ABA system. The presence of this antigen-specific, "idiotype positive" molecule in many different cells indicates that it is not an important immunoregulatory molecule.

References

Oct 1, 1978·The Journal of Experimental Medicine·G K Lewis, J W Goodman
Oct 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·J Oudin, P A Cazenave
Jul 1, 1974·Analytical Biochemistry·S C MarchP Cuatrecasas
Dec 1, 1980·Immunology·M J Taussig
Jul 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·K OkudaM E Dorf
Oct 1, 1980·The Journal of Experimental Medicine·L HarwellJ Kappler

❮ Previous
Next ❯

Citations

Jan 1, 1982·Immunogenetics·M SuzanB Rubin
Mar 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·K D BeamanR E Cone
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·C A Hasemann, J D Capra
Jul 1, 1982·The Journal of Experimental Medicine·L A Sherman
May 1, 1983·Immunology Today·J F MillerI D Walker
Dec 16, 1982·Nature·J C Jensenius, A F Williams
Mar 1, 1986·Microbiological Reviews·F W Fitch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.